Clinical trial
An Effectiveness and Safety Study of AQUAVAN® Injection (Fospropofol Disodium)…
NCT00306722 · Eisai Inc., Industry · Completed
Key facts
| NCT number | NCT00306722 |
|---|---|
| Title | An Effectiveness and Safety Study of AQUAVAN® Injection (Fospropofol Disodium) for Sedation During Flexible Bronchoscopy |
| Official title | A Phase 3, Randomized, Double-Blind, Dose-Controlled Study To Assess The Efficacy And Safety Of AQUAVAN® (Fospropofol Disodium) Injection For Minimal-To-Moderate Sedation In Patients Undergoing Flexible Bronchoscopy |
| Lead sponsor | Eisai Inc., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Bronchoscopy, Anesthesia |
| Intervention type | Drug |
| Interventions | AQUAVAN® (fospropofol disodium) Injection |
| Enrollment | 250 |
| Start date | Apr 1, 2006 |
| Completion | May 1, 2007 |
| First posted | Mar 24, 2006 |
| Last update posted | Nov 7, 2008 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: